Immunocomb chlamydia bivalent assay to study Chlamydia species-specific antibodies in patients with coronary heart disease

Indian Journal of Medical Research

Volumn 121, Issue 3, 2005, Pages 171-175

  Satpathy, Gita ^a   Sharma, Anjana ^a   Vasisht, Suman ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

C. trachomatis; Chlamydia pneumoniae; Coronary heart disease; Immunocomb Chlamydia bivalent assay; Microimmunofluorescence

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SPECIES DIFFERENCE;

AGED; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CORONARY DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; SPECIES SPECIFICITY;

EID: 17244380579     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992; 116 : 273-8.
2. Saikku P, Leinonen M, Mattila KJ, Ekman MR, Nieminen MS, Makeld PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; ii : 983-6.
3. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350 : 430-6.
4. Danesh J, Whincup P, Lewington S, Walker M, Lennon L, Thomson A, et al. Chlamydia pneumoniae IgA titres and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 2002; 23 : 371-5.
5. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268 : 68-72.
6. Kutlin A, Tsuma N, Emre U. Roblin P, Hammerschlag MR. Evaluation of chlamydia immunoglobulin (IgM, IgG & IgA) by ELISA for diagnosis of Chlamydia pneumoniae infection. Clin Diagn Lab Immunol 1997; 4 : 213-6.
7. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33 : 492-503.
8. Larsen MM, Moern B, Fuller A, Andersen PL, Ostergaard LJ. Chlamydia pneumoniae and cardiovascular disease. Med J Australia 2002; 177 : 558-62.
9. Gupta S, Camm AJ. Chlamydia pneumoniae and coronary heart disease. BMJ 1997; 314 : 1778-9.
10. Hermman C, Graf K, Groh A, Straube E, Hartung T. Comparison of eleven commercial tests for Chlamydia pneumoniae specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol 2002; 40 : 1603-9.
11. Treharne JD, Darougar S, Jones BR. Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection. J Clin Pathol 1977; 30: 510-7.
12. Saikku P. The epidemiology and significance of Chalmydia pneumoniae. J Infect 1992; 25 (Suppl 1) : 27-34.
13. Clad A, Fredank H, Plunnecke J, Jung B, Petersen EE. Chlamydia trachomatis species-specific serology: Immunocomb chlamydia bivalent versus microimmunofluorescence (MIF). Infection 1994; 22 : 165-73.
14. Nieto FJ. Folsom AR, Sorlie P, Grayston JT, Wang SP, Lloyd E. Chlamydia pneumoniae infection and incident coronary heart disease. The Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999; 150 : 149-56.
15. Satpathy G, Sharma A, Vishalakshi P. Species-specific chlamydiae antibodies in voluntary blood donors of Delhi. Indian J Med Res 2001; 114 : 164-8.
16. Forsey T, Darougar S, Treharne JD. Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of chlamydia. J Infect 1986; 12 : 145-52.
17. Sharma A, Satpathy G, Vashisht S, Wazir HS, Prakash P. Coronary heart diseases in patients with prior exposure to Chlamydia pneumoniae. J Basic Appl Biomed 1995; 3 : 37-40.
18. Mannion PT, Mallinson H, Treharne JD. Serological diagnosis with the Chlamydia spot-IF test. J Med Microbiol 1991; 35 : 244-8.
19. Schumacher A, Lerkerod AB, Seljeflot I, Sommervoll L, Holme I, Otterstad, Arnesen. Chlamydia pneumoniae serology: Importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol 2001; 39 : 1859-64.
20. Vainas T, De Graaf R, Stassen FR, Kurvers HA, Grauls GE, Kitslaar PJ, Bruggeman CA. Chlaydia pneumoniae serology: comparing a commercial enzyme immunoassay and micro immunofluorescence test in patients with cardiovascular disease. APMIS 2003; 111 : 363-9.
21. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10 : 160-84.